The Brighterside of News on MSN38m
New antiviral chewing gum blocks influenza and other infectious diseasesInfectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses ...
US researchers have developed an antiviral chewing gum using lablab beans that can reduce viral loads of herpes (HSV-1, HSV-2 ...
It's that time of year when flu vaccines are becoming available in Australia. You may have received an email from your GP ...
A team of US researchers have developed a new antiviral chewing gum that showed the potential to substantially reduce viral ...
In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic ...
Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
Common cold symptoms tend to affect the upper airways, like the nose, head, and throat. Learn how symptoms progress with a ...
Traws Pharma, Inc. ( NASDAQ: TRAW) Virtual Investor Event March 31, 2025 10:00 AM ET Werner Cautreels – Chief Executive Officer Robert Redfield – Chief Medical Officer David Pauza – Chief Science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback